News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Sharemaestro News Company research
Agilent Technologies added 1.8% for the week and is up 29.4% over 12 weeks, but the move is now 15.6% above Sharemaestro Fair Value on only 0.6x average volume.
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Russell Investments Group Ltd. has increased its stake in Agilent Technologies, Inc. by 11.3% in the second quarter, bringing its total holdings to 749,294 shares valued at approximately $99.5 million. This move comes as Agilent Technologies reported strong quarterly earnings, beating analyst estimates with …
Gilead Sciences is partnering with Nucleai for AI-powered tissue analytics to enhance its antibody-drug conjugate (ADC) clinical development and precision oncology efforts. This collaboration supports Gilead's long-term strategy to pivot into oncology, leveraging its strong HIV core business. However, despite the potential of AI-enabled …
Montag A & Associates Inc. significantly increased its stake in Agilent Technologies, Inc. (NYSE:A) by 911.5% in the second quarter, acquiring an additional 11,850 shares, bringing their total holdings to 13,150 shares valued at $1,750,000. Other institutional investors also adjusted their positions in the …
KBC Group NV increased its stake in Agilent Technologies, Inc. (NYSE:A) by 18.4% in the second quarter, bringing its total holdings to 81,883 shares valued at $10.88 million. Several other institutional investors also adjusted their positions in Agilent, while analysts have given the stock …
LFG Wealth Partners LLC recently invested $1.75 million in Agilent Technologies, Inc., acquiring 13,176 shares during the second quarter. Other institutional investors also increased their stakes in the company, which reported strong quarterly earnings and maintained its fiscal 2026 EPS guidance. Analyst sentiment for …
VCI Wealth Management LLC increased its stake in Agilent Technologies (NYSE:A) by 70.5% in the second quarter, acquiring an additional 9,105 shares, bringing its total holdings to 22,020 shares valued at $2.93 million. Agilent reported strong quarterly earnings, exceeding analyst estimates with an EPS …
Summit Global Investments initiated a new position in Gilead Sciences, acquiring 11,712 shares valued at $1.48 million during the second quarter. Gilead Sciences reported strong Q2 earnings, surpassing revenue and EPS expectations, with a 10.6% year-over-year revenue increase and declared a quarterly dividend of …
Centric Wealth Management has acquired a new stake of 26,506 shares in Gilead Sciences, Inc. (NASDAQ:GILD), valued at approximately $3.52 million during the second quarter. This move is part of broader institutional interest, with 83.67% of Gilead's stock owned by institutional investors and hedge …
Cornerstone Capital Inc. has acquired a new stake in Gilead Sciences, Inc., purchasing 36,158 shares valued at approximately $4.57 million during the second quarter. This move comes as institutional investors and hedge funds collectively own 83.67% of the company. Gilead recently reported stronger-than-expected quarterly …
111 Capital has acquired a new stake of 9,431 shares in Agilent Technologies, Inc. (NYSE:A) during the second quarter, valued at approximately $1.253 million. This comes as several other institutional investors also increased their holdings in the medical research company. Agilent Technologies recently reported …
Principal Financial Group Inc. reduced its stake in Agilent Technologies, Inc. by 5.4%, selling 18,893 shares and retaining 332,822 shares valued at approximately $44.2 million. Other institutional investors also adjusted their positions in Agilent, which reported strong quarterly earnings and year-over-year revenue growth. The …
TD Asset Management Inc. reduced its stake in Agilent Technologies (NYSE:A) by 2.6% in the second quarter, selling 26,544 shares but still holding 996,884 shares valued at $132.4 million. Despite this reduction, institutional investors collectively own a significant 87.41% of the company. Analysts maintain …
Qsemble Capital Management LP significantly reduced its stake in Agilent Technologies (NYSE:A) by 77.4% in the second quarter, selling 80,925 shares and retaining 23,610 shares valued at approximately $3.14 million. Despite this reduction, Agilent Technologies reported strong quarterly earnings of $1.49 per share, surpassing …
Massachusetts Financial Services Co. significantly reduced its stake in Agilent Technologies, selling 2.61 million shares, though still retaining 10.01 million shares valued at approximately $1.36 billion. Despite this sale, analysts generally maintain a "Moderate Buy" rating for Agilent, with a consensus price target of …
Oppenheimer Asset Management Inc. significantly increased its stake in Agilent Technologies (NYSE:A) by 75.9% in the second quarter, adding 41,794 shares and bringing its total holding to $12.9 million. This move is part of a broader trend where institutional investors and hedge funds own …
Jennison Associates LLC significantly increased its stake in Agilent Technologies (NYSE:A) by 81.3% in the second quarter, now owning 621,278 shares valued at $82.5 million. This comes as Agilent reported strong quarterly earnings, beating estimates with an EPS of $1.49 and a 10% revenue …
Vontobel Holding Ltd. decreased its stake in Agilent Technologies, Inc. (NYSE:A) by 18.7% in the second quarter, selling 8,489 shares and holding a total of 36,863 shares valued at $4.897 million. Several other institutional investors also adjusted their positions in Agilent, which currently holds …
NewEdge Advisors LLC significantly reduced its stake in Agilent Technologies, selling 10,106 shares, though institutional interest in the company remains strong with several firms increasing their holdings. Analysts maintain a "Moderate Buy" rating for Agilent, which recently surpassed earnings and revenue expectations with 10% …
Assenagon Asset Management S.A. significantly reduced its stake in Agilent Technologies (NYSE:A) by 75.3% in the second quarter, selling 31,934 shares. Despite this, other institutional investors like State Street Corp, Geode Capital Management LLC, and Morgan Stanley increased their holdings. Agilent Technologies reported strong …
Eurizon SLJ Capital Ltd has invested $10.13 million in Agilent Technologies, acquiring 76,249 shares, making it their ninth-largest holding. Agilent Technologies reported strong quarterly earnings, surpassing analyst expectations with $1.49 EPS and $1.83 billion in revenue, and provided positive fiscal year 2026 guidance. The …
Abundance Wealth Counselors significantly increased its stake in Gilead Sciences, Inc. by 93.7% in the second quarter, now holding 22,139 shares valued at $2.8 million. This comes as Gilead reported strong Q2 revenue growth of 10.6% to $7.8 billion, driven by its HIV franchise …
Gildan Activewear (TSE:GIL) shares recently fell below their 200-day moving average, trading at C$78.75 compared to the C$81.55 average. Despite this, analysts maintain a "Moderate Buy" consensus with an average price target of C$89.50. The company also declared a quarterly dividend of C$0.249, yielding …
Wall Street Zen has downgraded Ermenegildo Zegna (NYSE:ZGN) from a "buy" to a "hold" rating, contributing to a mixed analyst sentiment with an overall "Hold" consensus and an average price target of $13.13. Despite this, other analysts like TD Cowen, UBS Group, and JPMorgan …
Wall Street Zen has upgraded Gilead Sciences (NASDAQ:GILD) from a "Hold" to a "Buy" rating. This upgrade aligns with a "Moderate Buy" consensus among analysts, with an average price target of $158.04. The company recently reported strong quarterly results, exceeding revenue expectations, despite some …
Agilent Technologies (A) stock shows a mixed valuation, with its Discounted Cash Flow (DCF) model suggesting it is undervalued by 16.8%, indicating potential upside. However, its P/E ratio of 29.7x, while below the industry average, is above its modeled fair P/E of 24.1x, suggesting …
On August 11, Gilead Sciences, Inc. (NASDAQ:GILD) exercised its option to exclusively license a preclinical bispecific program targeting solid tumors using MacroGenics, Inc. (NASDAQ:MGNX)'s proprietary TRIDENT platform. The decision triggered a $10 million milestone payment to MacroGenics, injecting momentum into the companies' 2022 collaboration. …
Sharemaestro market context Price above Trend Line 52 weeks +42.5% · Next-week setup positive 55.2%Agilon Health Inc (AGL) saw its stock rise by 9.0% to $96.90, but GuruFocus's GF Value indicates the stock is overvalued by 6.2% compared to its intrinsic value of $91.24. Despite a strong GF Score of 71/100, driven by good growth and valuation ranks, …
Caisse de dépôt et placement du Québec has reported a 6.3% ownership stake in Gildan Activewear Inc. (GIL), holding 11,679,294 common shares. This information comes from a SCHEDULE 13G/A filing, indicating that Caisse de dépôt et placement du Québec possesses sole voting and dispositive …
Gilead Sciences (GILD) is gaining investor attention due to a new AI collaboration with Nucleai and positive Q2 results, though some analyses suggest it might be overvalued by about 8%. The company is transitioning into a multi-platform biopharma, but differing valuation models present varied …
A federal appeals court has upheld a preliminary injunction preventing companies from importing international versions of Gilead's HIV drug Biktarvy into the U.S. and distributing them via employer health plans. The court ruled that the overseas versions materially differ from FDA-regulated U.S. versions, highlighting …
Gildan Activewear Inc. (GIL) shares fell by 0.87% on Friday, closing at C$78.75. This performance underperformed the broader Canadian market, as the S&P/TSX Composite Index (GSPTSE) only declined by 0.08%. The company's stock is now 21.6% below its 52-week high of C$100.44, achieved on …
Sharemaestro market context Price below Trend Line 52 weeks +3.5% · Next-week setup positive 56.7%Search by ticker symbol or company name and select a result to open its chart.